CCR 20th anniversary commentary: Radioactive Drones for B-cell lymphoma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25646179.
- Also identified by DOI 10.1158/1078-0432.CCR-14-2547.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a study published in the March 1, 1996, issue of Clinical Cancer Research, Knox and colleagues (1) demonstrated the safety and efficacy of Yttirium-90 ((90)Y)-anti-CD20 monoclonal antibody therapy, as well as the benefit of preinfusion of unlabeled antibody on radiolabeled antibody biodistribution. Subsequent clinical trials with this radiolabeled antibody led to regulatory approval of this treatment for B-cell lymphoma. See related article by Knox et al., Clin Cancer Res 1996;2(3) Mar 1996; 457-70.
Medical subject headings
- Lymphoma, B-Cell
- Radioimmunotherapy